Elekta EKTAY recently announced that its Elekta Evo CT-Linac has received 510(k) clearance from the FDA, making the system ...
Elekta announced today that its Evo CT Linac received FDA 510(k) clearance, making it available to U.S. radiation oncology ...
TOWNSVILLE, Australia, Dec. 10, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that Townsville Hospital in Queensland has treated the first patient in Australia using Elekta Unity MR-Linac, a ...
ATLANTA, July 19, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has achieved regulatory certification from the ...
- Elekta Harmony to shorten treatment times and reduce footprint while maintaining high precision STOCKHOLM, Sept. 15, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) today introduced its Elekta Harmony* ...
GUWAHATI, India, Dec. 5, 2025 /PRNewswire/ -- Elekta announced the introduction of its latest linear accelerator (linac), Evo*, to the Indian market. Already launched in Europe and other regions, Evo ...
STOCKHOLM, Oct. 17, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announces that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has been awarded the Institute of Physics (IOP) Business ...
As the US-based Allegheny Health Network gears up to treat patients with its first Elekta Unity MR-Linac system, its radiation oncology team is benefiting from the collective experience of other early ...
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta (EKTA-B.ST) and Royal Philips (NYSE:PHG, AEX:PHIA) today announced the installation of a third high-field (1.5 Tesla) MR-guided linear accelerator ...
The FINANCIAL — Elekta (EKTA-B.ST), Royal Philips and The Netherlands Cancer Institute, (NKI, Amsterdam, the Netherlands) on April 17 announced the installation of a high-field (1.5 Tesla) MR-guided ...
The Elekta Unity treatment team at The Royal Marsden and the Institute of Cancer Research, London. (Courtesy: Elekta) The Elekta Unity, which received its CE mark in June 2018 and is being clinically ...